[Evaluation of the efficacy of medical screening of blood donors on preventing blood transfusion-transmitted infectious agents]

Transfus Clin Biol. 2016 May;23(2):98-102. doi: 10.1016/j.tracli.2015.11.001. Epub 2015 Dec 8.
[Article in French]

Abstract

Background: The aim of this study was to evaluate the efficacy of medical screening to retain blood donors in window period by comparing the seroprevalence of infectious agents (HIV, hepatitis B and C, syphilis) in deferred versus accepted blood donors.

Materials and methods: This prospective and transversal study was performed during 4 months in the National Blood Transfusion Center in Dakar (Senegal). We conducted a convenience sampling comparing the seroprevalence of infectious agents (HIV, HBsAg, HCV and syphilis) in deferred versus accepted blood donors after medical selection.

Results: In total, 8219 blood donors were included. Medical selection had authorized 8048 donors (97.92%) and deferred donors were 171 (2.08%). The prevalence of HIV was higher in the deferred than in accepted blood donors (1.75% vs. 0.05%) (P=0.0003; OR=35.91), as well as for HBsAg (12.87% vs. 7.35%) (P=0.006; OR=1.86). HCV antibodies were present in 0.71% of accepted blood donors and 0.58% in deferred blood donors (P=0.65; OR=0.82). Only accepted donors had brought the infection of syphilis (0.34%) (P=0.56; OR=0).

Conclusion: Medical selection is efficient to exclude blood donors at high risk of HIV transmission and to a lesser extent of HBV. However, current medical screening procedures do not allow us to exclude donors asymptomatic carriers of HCV and syphilis.

Keywords: Blood donors; Donneurs de sang; HBV; HCV; HIV; Medical screening; Sélection médicale; VHB; VHC; VIH.

MeSH terms

  • Adolescent
  • Adult
  • Bacteremia / diagnosis
  • Bacteremia / prevention & control
  • Bacteremia / transmission
  • Blood Donors*
  • Blood Safety*
  • Blood-Borne Pathogens*
  • Cross-Sectional Studies
  • HIV Infections / diagnosis
  • HIV Infections / epidemiology
  • HIV Infections / prevention & control*
  • Hepatitis, Viral, Human / diagnosis
  • Hepatitis, Viral, Human / epidemiology
  • Hepatitis, Viral, Human / prevention & control*
  • Humans
  • Mass Screening*
  • Middle Aged
  • Program Evaluation
  • Prospective Studies
  • Senegal / epidemiology
  • Seroepidemiologic Studies
  • Syphilis / diagnosis
  • Syphilis / epidemiology
  • Syphilis / prevention & control*
  • Transfusion Reaction*
  • Viremia / diagnosis
  • Viremia / prevention & control
  • Viremia / transmission
  • Young Adult